Aurinia Pharmaceuticals Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| AUPH | ALMS | AUTL | LYCA | VOR | CRVS | |
|---|---|---|---|---|---|---|
| Market cap | 2.29B | 847.80M | 367.30M | 1.51B | 1.24B | 889.16M |
| P/E (TTM) | 7.5 | — | — | — | 0.1 | — |
| Forward P/E | 14.8 | -2.3 | -2.2 | — | -5.7 | -9.9 |
| Price/book | 3.5 | 1.9 | 4.9 | -3.2 | -9.0 | 3.9 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +22.65% | +38.77% | +1.47% | −3.60% | −5.02% | +35.17% |
| Today | +3.32% | +0.77% | −2.47% | +4.78% | +1.31% | +7.53% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All AUPH news ›Aurinia Skids on Results
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced financial results for the three and nine months ended September 30, 2026 and provided an update on recent business progress. For the three and nine months ended September 30,…
Aurinia Pharmaceuticals Inc (AUPH) – What Are Analysts Saying About This Stock?
Posted by Danessa Lincoln on Oct 28th, 2026 Read Our Latest Stock Analysis on Aurinia Pharmaceuticals AUPH opened at $17.25 on Friday. Aurinia Pharmaceuticals has a 52 week low of $11.96 and a 52 week high of $19.25. The business’s fifty…
Financial Review: Aurinia Pharmaceuticals (NASDAQ:AUPH) & Pluri (NASDAQ:PLUR)
Posted by Kim Johansen on Oct 27th, 2026 Pluri (NASDAQ:PLUR – Get Free Report) and Aurinia Pharmaceuticals (NASDAQ:AUPH – Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two companies…
More from 1 other outlet
Aurinia Pharmaceuticals (NASDAQ:AUPH) and Shattuck Labs (NASDAQ:STTK) Financial Contrast
Posted by Tristan Rich on Oct 24th, 2026 Shattuck Labs (NASDAQ:STTK – Get Free Report) and Aurinia Pharmaceuticals (NASDAQ:AUPH – Get Free Report) are both healthcare companies, but which is the superior business? We will contrast the two…
Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock Price Crosses Above 50-Day Moving Average – Here’s What Happened
Posted by Michael Walen on Oct 9th, 2026 Aurinia Pharmaceuticals Inc (NASDAQ:AUPH – Get Free Report) (TSE:AUP)’s share price passed above its fifty day moving average during trading on Wednesday. The stock has a fifty day moving average of…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- themarketsdaily.com4
- baystreet.ca1
- defenseworld.net1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 6 articles, not a forecast.